BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6818673)

  • 1. Clinical and hormonal effects of testosterone undecanoate (TU) in male sexual impotence.
    Klepsch I; Măicănescu-Georgescu M; Marinescu L
    Endocrinologie; 1982; 20(4):289-93. PubMed ID: 6818673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men.
    Zhang GY; Gu YQ; Wang XH; Cui YG; Bremner WJ
    J Androl; 1998; 19(6):761-8. PubMed ID: 9876028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative and qualitative changes in serum luteinizing hormone after injectable testosterone undecanoate treatment in hypogonadal men.
    Gu YQ; Ge ZY; Zhang GY; Bremner WJ
    Asian J Androl; 2000 Mar; 2(1):65-71. PubMed ID: 11228940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hormonal pattern in alcoholic disease. I. Luteinizing hormone (LH), follicle-stimulating hormone (FSH) and testosterone.
    Simionescu L; Oprescu M; Protici M; Dimitriu V
    Endocrinologie; 1977; 15(1):45-9. PubMed ID: 557832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is routine hormonal measurement necessary in initial evaluation of men with erectile dysfunction?
    Acar D; Cayan S; Bozlu M; Akbay E
    Arch Androl; 2004; 50(4):247-53. PubMed ID: 15277002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study.
    von Eckardstein S; Nieschlag E
    J Androl; 2002; 23(3):419-25. PubMed ID: 12002444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of radical prostatectomy on serum hormone levels.
    Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
    J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The significance of dyshormonal changes in the hypothalamo-hypophyseal-gonadal system in the diagnosis of infertility and impotence in the male].
    Nikitinskaja LP
    Z Urol Nephrol; 1982 Nov; 75(11):789-92. PubMed ID: 6819736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body fat content and testosterone pharmacokinetics determine gonadotropin suppression after intramuscular injections of testosterone preparations in normal men.
    Kornmann B; Nieschlag E; Zitzmann M; Gromoll J; Simoni M; von Eckardstein S
    J Androl; 2009; 30(5):602-13. PubMed ID: 19342702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FSH, LH and testosterone blood level in patients with psychogenic impotence.
    Legros JJ; Franchimont P; Palem-Vliers M; Servais J
    Endocrinol Exp; 1973; 7(1):59-64. PubMed ID: 4541063
    [No Abstract]   [Full Text] [Related]  

  • 11. [The determination of prolactin levels in men suffering from impotence (author's transl)].
    Jimerez Cruz JF; Sanchez-Franco F; Allona Almagro A; Lovaco Castellano F
    J Urol (Paris); 1981; 87(7):437-9. PubMed ID: 6796626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal predictors of prostate cancer.
    Sofikerim M; Eskicorapci S; Oruç O; Ozen H
    Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Male sexual function after autologous blood or marrow transplantation.
    Schimmer AD; Ali V; Stewart AK; Imrie K; Keating A
    Biol Blood Marrow Transplant; 2001; 7(5):279-83. PubMed ID: 11400950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary and gonadal endocrine effects and pharmacokinetics of the novel luteinizing hormone-releasing hormone antagonist teverelix in healthy men--a first-dose-in-humans study.
    Erb K; Pechstein B; Schueler A; Engel J; Hermann R
    Clin Pharmacol Ther; 2000 Jun; 67(6):660-9. PubMed ID: 10872648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The observation of serum sexual hormone levels before and after treatment in male hyperthyroidisms].
    Zheng TS; Ye LX; Wu ZY
    Zhonghua Nan Ke Xue; 2005 Dec; 11(12):936-8. PubMed ID: 16398369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors for partial suppression of spermatogenesis of hormonal male contraception.
    Li JW; Gu YQ
    Asian J Androl; 2008 Sep; 10(5):723-30. PubMed ID: 18645675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual function.
    Chiang HS; Hwang TI; Hsui YS; Lin YC; Chen HE; Chen GC; Liao CH
    Int J Impot Res; 2007; 19(4):411-7. PubMed ID: 17538639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between sleep-related erections and testosterone levels in men.
    Granata AR; Rochira V; Lerchl A; Marrama P; Carani C
    J Androl; 1997; 18(5):522-7. PubMed ID: 9349750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Propedeutics of male sexual impotence].
    Netto Júnior NR
    Rev Paul Med; 1982; 99(1):25-8. PubMed ID: 6815764
    [No Abstract]   [Full Text] [Related]  

  • 20. A dose-response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate.
    Saad F; Gooren LJ; Haider A; Yassin A
    J Androl; 2008; 29(1):102-5. PubMed ID: 17916569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.